Early evaluation of sunitinib for the treatment of advanced gastroenteropancreatic neuroendocrine neoplasms via CT imaging: RECIST 1.1 or Choi Criteria?

Peer Review reports

Original Submission
1 Nov 2016	Submitted	Original manuscript
23 Nov 2016	Reviewed	Reviewer Report - Brian Allen
27 Nov 2016	Reviewed	Reviewer Report - Nicholas Rudnick
22 Dec 2016	Author responded	Author comments - Shi-Ting Feng
Resubmission - Version 2
22 Dec 2016	Submitted	Manuscript version 2
14 Feb 2017	Author responded	Author comments - Shi-Ting Feng
Resubmission - Version 3
14 Feb 2017	Submitted	Manuscript version 3
Publishing
21 Feb 2017	Editorially accepted
23 Feb 2017	Article published	10.1186/s12885-017-3150-7

Back to article page